Back to calendar
Regeneron Pharmaceuticals, Inc. (REGN) Earnings
REGN reports earnings on Thursday, October 29, 2026
earnings report
October 29, 2026 · Before Market Open
Q3 2026
Est. EPS: $15.90
Actual EPS: $14.29
EPS surprise: 40.69%
Company overview
Market Cap$80.8B
PriceUSD 784.36
P/E19.38
EPS (TTM)40.46
52-week high821.11
52-week low541.00
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees15,410